Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the Translational Research Committee of the Heart Failure Association-European Society of CardiologyEuropean heart journal, 2018-12, Vol.39 (48), p.4243-4254 [Peer Reviewed Journal]Attribution - NonCommercial ;The Author(s) 2018. Published by Oxford University Press on behalf of the European Society of Cardiology. 2018 ;ISSN: 0195-668X ;ISSN: 1522-9645 ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehy596 ;PMID: 30295797Full text available |
|
2 |
Material Type: Article
|
Heart failure in diabetes: effects of anti-hyperglycaemic drug therapyThe Lancet (British edition), 2015-05, Vol.385 (9982), p.2107-2117 [Peer Reviewed Journal]Elsevier Ltd ;2015 Elsevier Ltd ;Copyright © 2015 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited May 23, 2015 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(14)61402-1 ;PMID: 26009231 ;CODEN: LANCAOFull text available |
|
3 |
Material Type: Article
|
Metformin vs sulfonylurea use and risk of dementia in US veterans aged ≥65 years with diabetesNeurology, 2017-10, Vol.89 (18), p.1877-1885 [Peer Reviewed Journal]2017 American Academy of Neurology ;2017 American Academy of Neurology. ;2017 American Academy of Neurology 2017 American Academy of Neurology ;ISSN: 0028-3878 ;EISSN: 1526-632X ;DOI: 10.1212/WNL.0000000000004586 ;PMID: 28954880Full text available |
|
4 |
Material Type: Article
|
Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trialThe Lancet (British edition), 2013-09, Vol.382 (9896), p.941-950 [Peer Reviewed Journal]Elsevier Ltd ;2013 Elsevier Ltd ;2014 INIST-CNRS ;Copyright © 2013 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Sep 14, 2013 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(13)60683-2 ;PMID: 23850055 ;CODEN: LANCAOFull text available |
|
5 |
Material Type: Article
|
Central Mechanisms of Glucose Sensing and Counterregulation in Defense of HypoglycemiaEndocrine reviews, 2019-06, Vol.40 (3), p.768-788 [Peer Reviewed Journal]Copyright © 2019 Endocrine Society 2019 ;Copyright © Oxford University Press 2015 ;Copyright © 2019 Endocrine Society. ;COPYRIGHT 2019 Oxford University Press ;Copyright © 2019 Endocrine Society ;ISSN: 0163-769X ;EISSN: 1945-7189 ;DOI: 10.1210/er.2018-00226 ;PMID: 30689785Full text available |
|
6 |
Material Type: Article
|
Mechanisms of Hypoglycemia-Associated Autonomic Failure in DiabetesThe New England journal of medicine, 2013-07, Vol.369 (4), p.362-372 [Peer Reviewed Journal]Copyright © 2013 Massachusetts Medical Society. All rights reserved. ;2014 INIST-CNRS ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMra1215228 ;PMID: 23883381 ;CODEN: NEJMAGFull text available |
|
7 |
Material Type: Article
|
Sulfonylureas and the Risks of Cardiovascular Events and Death: A Methodological Meta-Regression Analysis of the Observational StudiesDiabetes care, 2017-05, Vol.40 (5), p.706-714 [Peer Reviewed Journal]2017 by the American Diabetes Association. ;Copyright American Diabetes Association May 2017 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc16-1943 ;PMID: 28428321Full text available |
|
8 |
Material Type: Article
|
SGLT2 Inhibitors in Combination Therapy: From Mechanisms to Clinical Considerations in Type 2 Diabetes ManagementDiabetes care, 2018-08, Vol.41 (8), p.1543-1556 [Peer Reviewed Journal]2018 by the American Diabetes Association. ;Copyright American Diabetes Association Aug 1, 2018 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc18-0588 ;PMID: 30030256Full text available |
|
9 |
Material Type: Article
|
Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controlsDiabetes, obesity & metabolism, 2014-11, Vol.16 (11), p.1165-11732014 John Wiley & Sons Ltd ;2014 John Wiley & Sons Ltd. ;ISSN: 1462-8902 ;EISSN: 1463-1326 ;DOI: 10.1111/dom.12354 ;PMID: 25041462 ;CODEN: DOMEF6Full text available |
|
10 |
Material Type: Article
|
Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort studyBMJ (Online), 2018-07, Vol.362, p.k2693 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2018 BMJ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to 2018 BMJ ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.k2693 ;PMID: 30021781Full text available |
|
11 |
Material Type: Article
|
Glycemia Reduction in Type 2 Diabetes — Glycemic OutcomesThe New England journal of medicine, 2022-09, Vol.387 (12), p.1063-1074 [Peer Reviewed Journal]Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;COPYRIGHT 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2200433 ;PMID: 36129996Full text available |
|
12 |
Material Type: Article
|
Comparative Effectiveness of SGLT2 Inhibitors, GLP-1 Receptor Agonists, DPP-4 Inhibitors, and Sulfonylureas on Risk of Kidney Outcomes: Emulation of a Target Trial Using Health Care DatabasesDiabetes care, 2020-11, Vol.43 (11), p.2859-2869 [Peer Reviewed Journal]2020 by the American Diabetes Association. ;Copyright American Diabetes Association Nov 1, 2020 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc20-1890 ;PMID: 32938746Full text available |
|
13 |
Material Type: Article
|
Glycemia Reduction in Type 2 Diabetes — Microvascular and Cardiovascular OutcomesThe New England journal of medicine, 2022-09, Vol.387 (12), p.1075-1088 [Peer Reviewed Journal]Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;COPYRIGHT 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2200436 ;PMID: 36129997Full text available |
|
14 |
Material Type: Article
|
Risk of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Addition of SGLT2 Inhibitors Versus Sulfonylureas to Baseline GLP-1RA TherapyCirculation (New York, N.Y.), 2021-02, Vol.143 (8), p.770-779 [Peer Reviewed Journal]ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.120.047965 ;PMID: 33302723Full text available |
|
15 |
Material Type: Article
|
Cancer Risk Associated with Use of Metformin and Sulfonylurea in Type 2 Diabetes: A Meta‐AnalysisThe oncologist (Dayton, Ohio), 2012, Vol.17 (6), p.813-822 [Peer Reviewed Journal]2012 AlphaMed Press ;AlphaMed Press 2012 ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.2011-0462 ;PMID: 22643536Full text available |
|
16 |
Material Type: Article
|
The Association between Sulfonylurea Use and All-Cause and Cardiovascular Mortality: A Meta-Analysis with Trial Sequential Analysis of Randomized Clinical TrialsPLoS medicine, 2016-04, Vol.13 (4), p.e1001992-e1001992 [Peer Reviewed Journal]COPYRIGHT 2016 Public Library of Science ;COPYRIGHT 2016 Public Library of Science ;2016 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Varvaki Rados D, Catani Pinto L, Reck Remonti L, Bauermann Leitão C, Gross JL (2016) The Association between Sulfonylurea Use and All-Cause and Cardiovascular Mortality: A Meta-Analysis with Trial Sequential Analysis of Randomized Clinical Trials. PLoS Med 13(4): e1001992. doi:10.1371/journal.pmed.1001992 ;2016 Varvaki Rados et al 2016 Varvaki Rados et al ;2016 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Varvaki Rados D, Catani Pinto L, Reck Remonti L, Bauermann Leitão C, Gross JL (2016) The Association between Sulfonylurea Use and All-Cause and Cardiovascular Mortality: A Meta-Analysis with Trial Sequential Analysis of Randomized Clinical Trials. PLoS Med 13(4): e1001992. doi:10.1371/journal.pmed.1001992 ;ISSN: 1549-1676 ;ISSN: 1549-1277 ;EISSN: 1549-1676 ;DOI: 10.1371/journal.pmed.1001992 ;PMID: 27071029Full text available |
|
17 |
Material Type: Article
|
Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysisDiabetes/metabolism research and reviews, 2012-02, Vol.28 (2), p.109-122 [Peer Reviewed Journal]Copyright © 2011 John Wiley & Sons, Ltd. ;ISSN: 1520-7552 ;EISSN: 1520-7560 ;DOI: 10.1002/dmrr.1291 ;PMID: 21898753Full text available |
|
18 |
Material Type: Article
|
Reappraisal of metformin efficacy in the treatment of type 2 diabetes: a meta-analysis of randomised controlled trialsPLoS medicine, 2012-04, Vol.9 (4), p.e1001204 [Peer Reviewed Journal]COPYRIGHT 2012 Public Library of Science ;COPYRIGHT 2012 Public Library of Science ;2012 Boussageon et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Boussageon R, Supper I, Bejan-Angoulvant T, Kellou N, Cucherat M, et al. (2012) Reappraisal of Metformin Efficacy in the Treatment of Type 2 Diabetes: A Meta-Analysis of Randomised Controlled Trials. PLoS Med 9(4): e1001204. doi:10.1371/journal.pmed.1001204 ;Distributed under a Creative Commons Attribution 4.0 International License ;Boussageon et al. 2012 ;ISSN: 1549-1676 ;ISSN: 1549-1277 ;EISSN: 1549-1676 ;DOI: 10.1371/journal.pmed.1001204 ;PMID: 22509138Full text available |
|
19 |
Material Type: Article
|
Diabetes and Cancer: A Consensus ReportCA: a cancer journal for clinicians, 2010-07, Vol.60 (4), p.207-221 [Peer Reviewed Journal]Copyright © 2010 American Cancer Society, Inc. ;(c) 2010 American Cancer Society, Inc. ;Copyright Lippincott Williams & Wilkins Jul/Aug 2010 ;ISSN: 0007-9235 ;EISSN: 1542-4863 ;DOI: 10.3322/caac.20078 ;PMID: 20554718 ;CODEN: CAMCAMFull text available |
|
20 |
Material Type: Article
|
Anti-diabetic medications and risk of pancreatic cancer in patients with diabetes mellitus: a systematic review and meta-analysisThe American journal of gastroenterology, 2013-04, Vol.108 (4), p.510-519 [Peer Reviewed Journal]Copyright Nature Publishing Group Apr 2013 ;ISSN: 0002-9270 ;EISSN: 1572-0241 ;DOI: 10.1038/ajg.2013.7 ;PMID: 23399556Full text available |